Isthmus Partners LLC trimmed its stake in NVE Co. (NASDAQ:NVEC – Free Report) by 16.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,972 shares of the semiconductor company’s stock after selling 8,519 shares during the quarter. Isthmus Partners LLC owned approximately 0.89% of NVE worth $3,432,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of NVEC. GSA Capital Partners LLP bought a new position in NVE in the third quarter valued at approximately $761,000. Oppenheimer & Close LLC bought a new position in NVE in the second quarter valued at approximately $575,000. Koss Olinger Consulting LLC bought a new position in NVE in the second quarter valued at approximately $460,000. Kings Path Partners LLC bought a new position in NVE in the second quarter valued at approximately $443,000. Finally, Allspring Global Investments Holdings LLC grew its stake in NVE by 127.9% in the second quarter. Allspring Global Investments Holdings LLC now owns 9,726 shares of the semiconductor company’s stock valued at $726,000 after purchasing an additional 5,459 shares in the last quarter. 65.95% of the stock is currently owned by institutional investors.
NVE Stock Up 0.3 %
NVEC stock opened at $77.09 on Friday. NVE Co. has a twelve month low of $69.73 and a twelve month high of $90.24. The business has a 50 day moving average price of $78.38 and a two-hundred day moving average price of $78.08. The company has a market cap of $372.34 million, a price-to-earnings ratio of 23.08 and a beta of 1.15.
NVE Dividend Announcement
NVE Company Profile
NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.
Featured Stories
- Five stocks we like better than NVE
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- 5 discounted opportunities for dividend growth investors
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for NVE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVE and related companies with MarketBeat.com's FREE daily email newsletter.